Sort
39,280 grants matching “leukemia”
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies
$402,262Kris C. Wood · Duke University · R01 · FY2023 · CA
Targeting to Epigenetic Modications in ALL
$402,250Scott A Armstrong · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Targeting to Epigenetic Modications in ALL
$402,250Scott A Armstrong · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Targeting to Epigenetic Modications in ALL
$402,250Scott A Armstrong · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Ex Vivo Culture of Umbilical Cord Blood Stem Cells for Adult Transplantation
$402,231Ronald L Brown · Quality Biological, Inc. · R44 · FY2008 · HL
Studies of other risk factors for radiosensitive tumors
$402,135Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
RESIDUAL DISEASE DETECTION IN ALL USING FLOW CYTOMETRY
$402,122Johns Hopkins University · R01 · FY2001 · CA
Cancer and Leukemia Group B - The Ohio State University
$402,122Ohio State University · U10 · FY2003 · CA
Novel analysis of association between microbiome and treatment infection in AML
$402,076Jianhua Hu · Columbia University Health Sciences · R01 · FY2020 · AI
MLL in Hematopoiesis and Leukemia in the Zebrafish Model
$402,071Carolyn A Felix · Children'S Hosp Of Philadelphia · R01 · FY2012 · CA
Novel analysis of association between microbiome and treatment infection in AML
$402,064Jianhua Hu · Columbia University Health Sciences · R01 · FY2021 · AI
Novel analysis of association between microbiome and treatment infection in AML
$402,049Jianhua Hu · Columbia University Health Sciences · R01 · FY2022 · AI
CORRELATED CLINICAL-LABORATORY PHASE I TRIALS
$402,038University Of Texas Md Anderson Can Ctr · U01 · FY2000 · CA
Novel analysis of association between microbiome and treatment infection in AML
$402,035Jianhua Hu · Columbia University Health Sciences · R01 · FY2023 · AI
Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms
$401,996Ann Mullally · Brigham And Women'S Hospital · R01 · FY2022 · HL
Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms
$401,996Ann Mullally · Brigham And Women'S Hospital · R01 · FY2023 · HL
Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms
$401,996Ann Mullally · Brigham And Women'S Hospital · R01 · FY2021 · HL
Chemo-Immunotherapy in Relapsed/Refactory B-Chronic Lymphocytic Leukemia
$401,851Neil E Kay · Mayo Clinic Rochester · R01 · FY2010 · CA
Design of inhibitors of drug-resistance protein kinases
$401,809Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$401,744Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2024 · CA
Molecular Basis of Drosophila Homeotic Gene Regulation
$401,708Peter J. Harte · Case Western Reserve University · R01 · FY2006 · GM
The Biology of Promyelocytic Leukemia in a Mouse Model
$401,685Washington University · R01 · FY2005 · CA
Molecular Basis of Drosophila Homeotic Gene Regulation
$401,670Peter J. Harte · Case Western Reserve University · R01 · FY2007 · GM
Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization
$401,635Wenyi Wei · Beth Israel Deaconess Medical Center · R01 · FY2016 · CA
Splicing Modulators for Rare Disease Indications
$401,631Richard E Taylor · University Of Notre Dame · R01 · FY2022 · GM